Levi & Korsinsky is investigating the Board of Directors of Williams Controls Inc. (“Williams Controls” or the “Company”) (NYSE MKT: WMCO) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Curtiss-Wright Corporation (NYSE: CW).
Click here to learn more about the investigation http://zlk.9nl.com/williams-controls-wmco/, or call: 877-363-5972. There is no cost or obligation to you.
Under the terms of the transaction, Williams Controls shareholders will receive $15.42 for each share of Williams Controls stock they own. The transaction has a total approximate value of $119 million. Shareholders owning an approximate 26% of the Company’s outstanding shares have agreed to tender their shares. The investigation concerns whether the Williams Controls Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before entering into this transaction and whether Curtiss-Wright is underpaying for Williams Controls shares, thus unlawfully harming Williams Controls stockholders.
If you own common stock in Williams Controls and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at firstname.lastname@example.org or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/williams-controls-wmco/.Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.